Dental stem cells have emerged as a promising therapeutic entity for the treatment of various dental and related maxillofacial conditions. Dental stem cells (DSCs) are mesenchymal stem cells derived from the dental tissue, including the periodontal ligament, dental pulp, deciduous teeth, and their surrounding hard and soft tissue. DSCs are capable of self-renewal, unlimited expansion, and multipotent differentiation. The efficacy of DSCs for the treatment of a wide range of dental and maxillofacial conditions has been documented in various in vitro and in vivo studies. A key advantage of DSCs compared to other traditional stem cells is their ability to be displaced from the site of injury and migrate to the area of injury. This is beneficial as it enables accurate and focused delivery of the stem cells, thus providing an efficient and precise approach to treating damaged tissue. Furthermore, their use generally produces no immunomodulatory response, making them ideal for autologous transplantation. Due to their therapeutic potential, much research regarding DSCs has been conducted in recent years. DSCs have shown potential to regenerate bone structures of the mouth, such as alveolar bone, and dentin. DSCs have also been proven to stimulate cementoblast differentiation in vitro which could potentially lead to the development of new ways of treating periodontal diseases. DSCs also have potential for treating congenital orofacial clefting and for regenerating other dental and maxillofacial tissues such as periodontal ligament and dentin. In addition, to their therapeutic potential, many studies have also shown that DSCs have immunomodulatory properties which could be beneficial for various clinical applications. For instance, DSCs have the potential to play a role in tissue engineering for the regeneration and repair of soft and hard tissue. Due to their immunomodulatory properties, DSCs could be used as a therapeutic agent to treat orthopedic conditions, such as cartilage damage. In conclusion, the growing use of DSCs in dentistry has huge potential for treatments of multiple dental and other maxillofacial conditions. Studies have shown success in a wide range of therapeutic potential, which include regeneration of bone and dentin, modulation of immune responses and tissue engineering.
Title : Atypical facial pain – a mistaken diagnosis
Christopher Turner, Spacemark Dental, United Kingdom
Title : Occlusion and implants
Christopher Turner, Spacemark Dental, United Kingdom
Title : Personalized and Precision Medicine (PPM) through biodesign inspired translational applications and the integration of dentistry into interprofessional healthcare to secure human oral health and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine and its clinical applications in oral health and diseases
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Revolutionizing periodontics and implant dentistry: The synergy of AI and laser technology
Preetinder Singh, Academy of Oral Surgery, United States
Title : Updated principles of facial trauma surgery 2027
Steven J Traub, American Institute of Oral Biology, United States